News
The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
2d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results